Zimmer Biomet (ZBH) analyst forecast and price target
Analyst forecast
Consensus of 29 analyst ratings
Based on 8 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $100.00 from $83.00 | Aug 10, 2026 |
| Truist Securities | Maintained | Hold | $106.00 from $92.00 | Aug 7, 2026 |
| Stifel | Maintained | Buy | $110.00 from $105.00 | Aug 6, 2026 |
| Bernstein | Maintained | Market Perform | $93.00 from $91.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $110.00 from $101.00 | Aug 6, 2026 |
| UBS | Initiated Coverage | Sell → Buy | $115.00 from $89.00 | Jul 28, 2026 |
| BMO Capital | Initiated Coverage | Outperform → Market Perform | $95.00 | Jul 9, 2026 |
| Evercore ISI Group | Maintained | Outperform | $110.00 from $120.00 | Jul 6, 2026 |
| Citigroup | Maintained | Neutral | $93.00 from $95.00 | May 28, 2026 |
| Stifel | Maintained | Buy | $105.00 from $110.00 | Apr 29, 2026 |
| Truist Securities | Maintained | Hold | $92.00 from $98.00 | Apr 29, 2026 |
| Barclays | Maintained | Underweight | $94.00 from $100.00 | Apr 29, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $90.00 from $98.00 | Apr 29, 2026 |
| Citigroup | Maintained | Neutral | $95.00 from $98.00 | Apr 29, 2026 |
| JP Morgan | Maintained | Neutral | $95.00 from $100.00 | Apr 29, 2026 |
| Citizens | Maintained | Market Outperform | $105.00 from $120.00 | Apr 29, 2026 |
| Leerink Partners | Initiated Coverage | Market Perform | $101.00 | Apr 13, 2026 |
| BTIG | Downgraded | Buy → Neutral | — | Mar 23, 2026 |
| Barclays | Maintained | Underweight | $100.00 from $104.00 | Feb 12, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $98.00 from $93.00 | Feb 11, 2026 |
Frequently asked questions
What is the price target for ZBH stock?
The average 12-month analyst price target for Zimmer Biomet (ZBH) is $104.88, with a high estimate of $115.00 and a low of $93.00, across 8 analysts.
Is ZBH a buy, sell, or hold?
Analysts covering Zimmer Biomet currently average a Hold rating: 8 buy, 21 hold and 0 sell, from 29 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ZBH?
The average price target of $104.88 implies 4.95% upside from the last price of $99.93.
What is the latest analyst rating on ZBH?
On Aug 10, 2026, Canaccord Genuity maintained Zimmer Biomet at Hold with a price target of $100.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.